| Date Filed | Type | Description |
| 04/29/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 03/13/2013 |
RW
| Form RW - Registration Withdrawal Request |
| 03/13/2013 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 03/12/2013 |
8-K
| Quarterly results |
| 03/11/2013 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 03/08/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/08/2013 |
4
| Cobb Terrell (Director) has filed a Form 4 on Pernix Sleep, Inc. |
| 03/08/2013 |
4
| MAST ERLE T (Director) has filed a Form 4 on Pernix Sleep, Inc. |
| 03/08/2013 |
4
| Hasnain Faheem (Director) has filed a Form 4 on Pernix Sleep, Inc. |
| 03/08/2013 |
4
| Dorsey Brian (SVP, Technical Operations) has filed a Form 4 on Pernix Sleep, Inc. |
| 03/08/2013 |
4
| Onaitis Matthew (SVP, General Counsel) has filed a Form 4 on Pernix Sleep, Inc. |
| 03/08/2013 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on Pernix Sleep, Inc. |
| 03/08/2013 |
4
| Pascoe Richard W (President and CEO) has filed a Form 4 on Pernix Sleep, Inc. |
| 03/08/2013 |
4
| HALE DAVID F (Director) has filed a Form 4 on Pernix Sleep, Inc. |
| 03/08/2013 |
S-3/A
| Form S-3 - Registration statement under Securities Act of 1933 [amend] |
| 03/08/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/06/2013 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 02/14/2013 |
SC 13G/A
| ISZO CAPITAL LP reports a 4.2% stake in Somaxon Pharmaceuticals, Inc. |
| 02/07/2013 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition |
| 02/05/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 02/04/2013 |
SC 13G
| MMCAP International Inc. SPC reports a 6.3% stake in SOMAXON PHARMACEUTICALS, INC. |
| 02/01/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 01/18/2013 |
SC 13G
| RTW INVESTMENTS, LLC reports a 5.4% stake in SOMAXON PHARMACEUTICALS, INC. |
| 01/03/2013 |
4
| Dorsey Brian (SVP, Technical Operations) has filed a Form 4 on Somaxon Pharmaceuticals, Inc. |
| 01/03/2013 |
4
| Nguyen Tran (SVP and CFO) has filed a Form 4 on Somaxon Pharmaceuticals, Inc. |
| 01/03/2013 |
4
| Pascoe Richard W (President and CEO) has filed a Form 4 on Somaxon Pharmaceuticals, Inc. |
| 01/03/2013 |
4
| EMSTER KURT VON (Director) has filed a Form 4 on Somaxon Pharmaceuticals, Inc. |
| 01/03/2013 |
4
| MAST ERLE T (Director) has filed a Form 4 on Somaxon Pharmaceuticals, Inc. |
| 01/03/2013 |
4
| Hasnain Faheem (Director) has filed a Form 4 on Somaxon Pharmaceuticals, Inc. |
| 01/03/2013 |
4
| EAGLE MICHAEL L (Director) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.|
Txns:
| Granted 7,918 shares
@ $0 |
|
| 01/03/2013 |
4
| Cobb Terrell (Director) has filed a Form 4 on Somaxon Pharmaceuticals, Inc. |
| 01/03/2013 |
4
| HALE DAVID F (Director) has filed a Form 4 on Somaxon Pharmaceuticals, Inc. |
| 12/21/2012 |
SC 13G
| ISZO CAPITAL LP reports a 8.9% stake in Somaxon Pharmaceuticals, Inc. |
| 12/21/2012 |
8-K
| Other Events |
|